# Diuretic Comparison Project

Study · id `cardio:ct-nct02185417` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02185417](<https://clinicaltrials.gov/study/NCT02185417>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02185417

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 20723 participants.

## Technical summary

Registry record NCT02185417. Randomized; no masking; primary purpose treatment. Start 2016-06-15 (actual); primary completion 2022-10-15 (actual). Results posted on 2024-05-22.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 20723 participants (enrolled count; ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Started: 2016-06-15 (actual) (ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Primary completion: 2022-10-15 (actual) (ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Completion: 2022-12-29 (actual) (ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Results first posted: 2024-05-22 (ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Countries: United States; Puerto Rico (ClinicalTrials.gov record NCT02185417, source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02185417-2024-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Diuretic Comparison Project
- Acronym: DCP
- Condition: Hypertension
- Intervention (Drug): Hydrochlorothiazide (HCTZ)
- Intervention (Drug): Chlorthalidone (CTD)
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention is a member of this class by a sourced record link: Thiazide and thiazide-like diuretics (`cardio:thiazide-and-thiazide-like-diuretics`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events (`cardio:pubmed-36516076`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials: A Secondary Analysis of the Diuretic Comparison Project (`cardio:pubmed-37656456`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke: A Secondary Analysis of a Randomized Clinical Trial (`cardio:pubmed-38743423`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial (`cardio:pubmed-39656458`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ac9ac861bf67c2fef64c1dadf0abe811c31052e8e98d5709d9e53b501cd5da9c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
